Your fact-checks will appear here
GLP-1–class drugs, including tirzepatide and semaglutide, are used for weight loss and diabetes management, with substantial benefits and documented risks.
Type 2 diabetes treatment is a multi‑pillar, person‑centered strategy combining lifestyle change, glucose‑lowering drugs, technology, and—when appropriate—surgical or endoscopic procedures; the 2026 A...
Stopping GLP‑1 receptor agonists commonly leads to substantial and often rapid weight regain and reversal of cardiometabolic improvements, and current trial and real‑world data show many patients disc...